Shares of Moderna Inc. MRNA shed 2.36% to $64.14 Monday, on what proved to be an all-around positive trading session for the ...

NDAQ:MRNA) Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNA ...

Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...

Moderna shares are down for the second day in a row after the company said it would slash its research and development costs.

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...